What is the prevalence of Critical limb ischemia?
How many people does Critical limb ischemia affect? Does it have the same prevalence in men and women? And in the different countries?
Critical limb ischemia (CLI) is a severe form of peripheral artery disease that results in significantly reduced blood flow to the limbs, leading to tissue damage and potential limb loss. The prevalence of CLI varies depending on the population studied and the region, but it is estimated to affect approximately 1-3% of the general population over the age of 60. CLI is more common in individuals with diabetes, hypertension, and a history of smoking. Early diagnosis and appropriate management are crucial to prevent complications and improve outcomes for patients with CLI.
Critical limb ischemia (CLI) is a severe form of peripheral arterial disease (PAD) that results in inadequate blood flow to the lower extremities. It is characterized by chronic ischemic rest pain, non-healing wounds, and tissue loss, which can ultimately lead to limb amputation if left untreated. CLI primarily affects individuals with advanced age, diabetes, smoking history, and other cardiovascular risk factors.
Estimating the exact prevalence of CLI can be challenging due to variations in study populations and diagnostic criteria. However, it is generally recognized as a relatively rare condition. Studies suggest that the prevalence of CLI ranges from 500 to 1000 cases per million population. The incidence of CLI increases with age, with a higher prevalence observed in individuals over 60 years old.
CLI poses a significant burden on healthcare systems and patients alike. It is associated with substantial morbidity, mortality, and reduced quality of life. Early diagnosis and appropriate management are crucial in preventing disease progression and improving outcomes for individuals with CLI.
